$1.73
+0 (+0%)
At Close: Aug 27, 2024
Two Sigma Advisers LP Has $1.54 Million Position in Eiger Biopharmaceuticals Inc (NASDAQ:EIGR)
06:26am, Thursday, 02'nd Jul 2020
Two Sigma Advisers LP grew its stake in Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) by 216.2% in the first quarter, according to the company in its most recent filing with the Securities and Exchange C
Rhythm Pharmaceuticals (RYTM) Received its Third Buy in a Row - Markets
05:09pm, Wednesday, 01'st Jul 2020
After Canaccord Genuity and Needham gave Rhythm Pharmaceuticals (NASDAQ: RYTM) a Buy rating last month, the company received another Buy,
Ladenburg Thalmann & Co. Maintains a Buy Rating on Marinus (MRNS) - Markets
10:38am, Wednesday, 01'st Jul 2020
In a report released today, Michael Higgins from Ladenburg Thalmann & Co. maintained a Buy rating on Marinus (MRNS –
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Achieve Life Sciences (ACHV –
Why Eiger BioPharmaceuticals (EIGR) Stock Might be a Great Pick
12:32pm, Wednesday, 24'th Jun 2020
Eiger BioPharmaceuticals (EIGR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Two Sigma Investments LP Increases Holdings in Eiger Biopharmaceuticals Inc (NASDAQ:EIGR)
08:02am, Monday, 22'nd Jun 2020
Two Sigma Investments LP grew its holdings in shares of Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) by 112.6% in the first quarter, according to its most recent filing with the Securities and Exchange
Wall Street Analysts Are Bullish on Top Healthcare Picks - Markets
10:27am, Wednesday, 17'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xenetic Biosciences
Aquestive Therapeutics (AQST) Receives a Buy from Wedbush - Markets
12:16pm, Sunday, 14'th Jun 2020
In a report issued on June 12, Liana Moussatos from Wedbush maintained a Buy rating on Aquestive Therapeutics (AQST –
Hedge Funds Can’t Buy Enough Of Eiger BioPharmaceuticals, Inc. (EIGR)
05:22pm, Monday, 08'th Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
Eiger BioPharmaceuticals, Inc. to Hold Virtual Annual Meeting of Stockholders on June 15, 2020
08:05pm, Friday, 29'th May 2020
Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR) announced today that, due to public health and safety concerns related to the COVID-19 global pandemic, recommendations and orders from federal, state and
The
Eiger to Present at Jefferies Virtual Healthcare Conference 2020
08:05pm, Tuesday, 26'th May 2020
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that Eiger management wil
May 25, 2020 (CDN Newswire via Comtex) --
Global Dilated Cardiomyopathy Therapeutic Market 2020 by Company, Regions, Type and Application, Forecast to 2026...
The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test
12:12pm, Wednesday, 20'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 19) * ADC Therapeutics SA (NYSE: ADCT) (IPOed May 15) * A
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that the U.S. Food and Dr
Sign In
Buy EIGR